CD 19 Test Purpose

The CD19 Test measures the number or percentage of CD19-positive B lymphocytes (B cells) in the blood using flow cytometry. CD19 is a protein found on the surface of most B cells, which are an essential part of the immune system responsible for producing antibodies and protecting the body against infections. Measuring CD19-positive cells helps evaluate immune function and diagnose various hematological and immunological disorders.

Healthcare providers commonly recommend the CD19 Test for individuals with recurrent infections, suspected primary immunodeficiency, unexplained low antibody levels, autoimmune disorders, or blood cancers such as B-cell leukemia and B-cell lymphoma. The test is also widely used to monitor patients receiving B-cell-depleting therapies, such as rituximab or other targeted immunotherapies.

Furthermore, abnormal CD19 cell counts may indicate primary immunodeficiency disorders, chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma, autoimmune diseases, or bone marrow disorders. A decreased CD19 count may be seen after B-cell-targeted treatments or in certain immune deficiencies, while an increased CD19 count may occur in some lymphoproliferative disorders. However, abnormal results alone are not sufficient to establish a diagnosis and should always be interpreted in the context of the patient’s clinical condition and other laboratory findings.

The CD19 Test is often performed alongside CD3, CD4, CD8, CD20, CD45, Complete Blood Count (CBC), Serum Immunoglobulin Levels (IgG, IgA, IgM), Flow Cytometry Immunophenotyping, and Bone Marrow Examination to provide a comprehensive evaluation of immune function and blood disorders.

The test results should always be interpreted together with the patient’s symptoms, medical history, medication use, physical examination, and additional laboratory investigations. Monitoring CD19 levels over time can help assess disease progression, immune recovery, and response to therapy.

 Test is Recommended for Individuals:

• Individuals with recurrent or severe infections.
• Patients with suspected primary or secondary immunodeficiency.
• People diagnosed with B-cell leukemia or B-cell lymphoma.
• Individuals undergoing rituximab or other B-cell-targeted therapies.
• Patients with autoimmune disorders requiring immune monitoring.
• Individuals undergoing immune status evaluation before or after treatment.
• Patients advised by their hematologist, oncologist, or immunologist to undergo CD19 testing.

FAQs

1. What is the CD19 Test used for?

The CD19 Test measures CD19-positive B lymphocytes in the blood. It helps evaluate immune system function, diagnose B-cell disorders, monitor leukemia or lymphoma, and assess the response to B-cell-targeted therapies.

2. Do I need to fast before the CD19 Test?

No, fasting is generally not required for the CD19 Test. However, always follow any specific instructions given by your healthcare provider before sample collection.

3. What do abnormal CD19 levels mean?

Low CD19 levels may indicate B-cell depletion due to immunotherapy, primary immunodeficiency, or bone marrow disorders, while high CD19 levels may be associated with B-cell leukemia, lymphoma, or other lymphoproliferative disorders. Your healthcare provider will interpret the results together with your symptoms, medical history, and other laboratory tests to determine the underlying cause and recommend appropriate management.